
This article was originally distributed via PRWeb. PRWeb, WorldNow and this Site make no warranties or representations in connection therewith.
SOURCE: Xtalks
Xtalks presents an exciting live webinar on Wednesday February 13, 2013 at 10:00am EST on choosing the right sites for your clinical trials. Join keynote speakers Chris Frega, Sr. Director and Head of Global Feasibility at Quintiles and Tom Larrichio, Senior Director, Strategic Site Intelligence at Quintiles.
Toronto, Canada (PRWEB) January 29, 2013
In this webinar, experts will discuss best practices for using data to assess the best fit countries and associated sites for particular trials. Speakers will present methods for identifying key success factors for each country, options for measuring key success factors, and how to determine an optimal country strategy to ensure successful delivery of clinical trials.
By reviewing case studies, experts will highlight best practices for analysis, collection, and determining data type. Developing the right algorithm to help determine the best fit countries and sites for your trial or program will be reviewed.
By attending this webinar, you will learn:
This presentation is a challenge to the industry to think objectively and spend additional time and effort in planning their clinical trial strategies.
For more information about this event or to register, visit: http://xtks.in/xto550-event
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com/ContactUs.ashx
Contact:
Karen Lim (416) 977-6555 ext 227
clientservices(at)xtalks(dot)com
For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2013/1/prweb10369709.htm